Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Borroni

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1995
Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotidesA Bourson, E Borroni, R H Austin, et al.
Behavioural Brain Research|January 1, 1996
Effects of altered 5-ht6 expression in the rat: functional studies using antisense oligonucleotidesA J Sleight, F J Monsma, E Borroni, et al.
Archives of Biochemistry and Biophysics|July 1, 1990
Further studies on the gangliosidic nature of the cholinergic-specific antigen, Chol-1A Giuliani, E Calappi, E Borroni, et al.
Psychopharmacology|January 1, 1980
Further studies on the mechanism of serotonin-dependent anorexia in ratsR Samanin, S Caccia, C Bendotti, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 29, 2000
Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT)B Masjost, P Ballmer, E Borroni, et al.
Cancer Medicine|April 11, 2019
Fixed combination of oral NEPA (netupitant-palonosetron) for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double-blind phase III studiesLee Schwartzberg, Meinolf Karthaus, Giorgia Rossi, et al.
Journal of Neural Transmission. Supplementum|June 13, 1998
Monoamine oxidases: from brain maps to physiology and transgenics to pathophysiologyJ G Richards, J Saura, J M Luque, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2014
A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapyR J Gralla, S M Bosnjak, A Hontsa, et al.
The Pharmacogenomics Journal|August 9, 2007
Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in miceM A Steiner, K Wanisch, K Monory, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 26, 2011
PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disordersS Saenger, C Goeldner, J R Frey, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1995
Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotidesA Bourson, E Borroni, R H Austin, et al.
Behavioural Brain Research|January 1, 1996
Effects of altered 5-ht6 expression in the rat: functional studies using antisense oligonucleotidesA J Sleight, F J Monsma, E Borroni, et al.
Archives of Biochemistry and Biophysics|July 1, 1990
Further studies on the gangliosidic nature of the cholinergic-specific antigen, Chol-1A Giuliani, E Calappi, E Borroni, et al.
Psychopharmacology|January 1, 1980
Further studies on the mechanism of serotonin-dependent anorexia in ratsR Samanin, S Caccia, C Bendotti, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 29, 2000
Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT)B Masjost, P Ballmer, E Borroni, et al.
Cancer Medicine|April 11, 2019
Fixed combination of oral NEPA (netupitant-palonosetron) for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double-blind phase III studiesLee Schwartzberg, Meinolf Karthaus, Giorgia Rossi, et al.
Journal of Neural Transmission. Supplementum|June 13, 1998
Monoamine oxidases: from brain maps to physiology and transgenics to pathophysiologyJ G Richards, J Saura, J M Luque, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2014
A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapyR J Gralla, S M Bosnjak, A Hontsa, et al.
The Pharmacogenomics Journal|August 9, 2007
Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in miceM A Steiner, K Wanisch, K Monory, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 26, 2011
PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disordersS Saenger, C Goeldner, J R Frey, et al.
Pageof 4